14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 19, 2026
RDN vs ACT: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 19, 2026, Radian Group Inc. (RDN) is the stronger overall head-to-head candidate over Enact Holdings, Inc. (ACT) in the Tradestie Institutional Equity Comparison Engine, winning 4–6 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Balance Sheet & Cash Flow). RDN carries a Unified Composite Score of 34.9/100 (SELL) at $36.47 (6.9x Forward P/E, 45.4% operating margin), whereas ACT carries 44.1/100 (HOLD) at $44.19 (8.9x Forward P/E, 72.5% operating margin).
Composite vs. Pillar Nuance: While ACT currently prints a higher short-term Unified Composite Score (44.1/100 HOLD vs. RDN 34.9/100 SELL), RDN captures the overall institutional head-to-head verdict (4–6 matrix metrics and 4–2 across the 6 pillars) due to superior fundamental profitability (45.4% vs. 72.5% operating margin) and revenue trajectory (+105.7% vs. +0.4% YoY).
Technical & Structure Timing Caution: RDN trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 54.6); meanwhile ACT is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 34.7). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on RDN vs ACT. Trailing 12-month operating profitability (RDN 45.4% vs ACT 72.5%) and valuation multiples (RDN 6.9x vs ACT 8.9x Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Insurance - Specialty value chain with $4.6B market capitalization and 45.4% operating margin.
OpEx & R&D Reinvestment17.1% of Rev ($337M)
90D Engineering Disclosures0 Published
ACT Moat ProfileHigh-Margin Pricing Power Moat
Insurance - Specialty Operator
Competes within the Insurance - Specialty value chain with $6.1B market capitalization and 72.5% operating margin.
OpEx & R&D ReinvestmentN/A
90D Engineering Disclosures0 Published
Investor FAQ RDN vs ACT Key Questions & Quantitative Answers
As of Nov 19, 2026, Radian Group Inc. (RDN) is the stronger overall head-to-head candidate over Enact Holdings, Inc. (ACT) in the Tradestie Institutional Equity Comparison Engine, winning 4–6 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Balance Sheet & Cash Flow). RDN carries a Unified Composite Score of 34.9/100 (SELL) at $36.47 (6.9x Forward P/E, 45.4% operating margin), whereas ACT carries 44.1/100 (HOLD) at $44.19 (8.9x Forward P/E, 72.5% operating margin). Composite vs. Pillar Nuance: While ACT currently prints a higher short-term Unified Composite Score (44.1/100 HOLD vs. RDN 34.9/100 SELL), RDN captures the overall institutional head-to-head verdict (4–6 matrix metrics and 4–2 across the 6 pillars) due to superior fundamental profitability (45.4% vs. 72.5% operating margin) and revenue trajectory (+105.7% vs. +0.4% YoY). Technical & Structure Timing Caution: RDN trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 54.6); meanwhile ACT is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 34.7). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
RDN leads the Growth & Scale pillar: RDN posts +105.7% YoY revenue growth and +18.4% YoY earnings growth on $1.97B TTM revenue (62.5% gross margin, 45.4% operating margin), compared with ACT at +0.4% YoY revenue growth and +4.5% YoY earnings growth on $1.25B TTM revenue (72.5% gross margin, 72.5% operating margin). On trailing 12-month operating scale, RDN generates $1.97B in USD-normalized revenue versus $1.25B for ACT. In operating R&D and SG&A reinvestment, RDN deploys 17.1% of Rev ($337M) (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for ACT.
RDN screens cheaper on headline valuation multiples. RDN trades at 6.9x Forward P/E, 8.7x Trailing P/E, 0.76x PEG, and 2.3x EV/Revenue (48.1% EBITDA margin), whereas ACT trades at 8.9x Forward P/E, 9.4x Trailing P/E, N/M PEG, and 5.0x EV/Revenue (56.8% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against RDN (12.4% ROE) versus ACT (12.9% ROE) capital efficiency.
In options market volatility and institutional positioning, RDN carries 28.8% implied volatility (5th %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (-0.07β · 26% Vol realized risk). By comparison, ACT carries 39.7% implied volatility (15th %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, DISTRIBUTION on-balance volume, and sits in a CONSOLIDATION options structure phase (0.03β · 22% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 19, 2026. For educational research only; not investment advice.